Dexcom Files Definitive Proxy Statement
Ticker: DXCM · Form: DEFA14A · Filed: Apr 15, 2026 · CIK: 0001093557
| Field | Detail |
|---|---|
| Company | Dexcom INC (DXCM) |
| Form Type | DEFA14A |
| Filed Date | Apr 15, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-filing, regulatory
Related Tickers: DXCM
TL;DR
Dexcom filed proxy docs 4/15/26 - shareholder vote incoming.
AI Summary
Dexcom Inc. filed a Definitive Proxy Statement (DEFA14A) on April 15, 2026. This filing is related to soliciting materials for shareholder votes. The company's principal executive offices are located at 6340 Sequence Drive, San Diego, CA 92121.
Why It Matters
This filing indicates that Dexcom is proceeding with shareholder matters, which could involve important corporate decisions or elections.
Risk Assessment
Risk Level: low — A DEFA14A filing is a standard regulatory document for soliciting shareholder votes and does not inherently indicate increased risk.
Key Players & Entities
- DEXCOM INC (company) — Filer
- 0001093557 (company) — CIK Number
- 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 (company) — Mailing and Business Address
- 2026-04-15 (date) — Filing Date
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for additional definitive proxy soliciting materials and Rule 14(a)(12) material, typically related to shareholder meetings and votes.
When was this DEFA14A filing submitted by Dexcom Inc.?
The filing date for this DEFA14A was April 15, 2026.
What is Dexcom Inc.'s CIK number?
Dexcom Inc.'s CIK number is 0001093557.
Where are Dexcom Inc.'s principal executive offices located?
Dexcom Inc.'s principal executive offices are located at 6340 Sequence Drive, San Diego, CA 92121.
What is the SIC code associated with Dexcom Inc.?
The SIC code associated with Dexcom Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 15, 2026 regarding DEXCOM INC (DXCM).